Literature DB >> 12385408

Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy.

Claudio Velati1, Luisa Romanò, Lorella Baruffi, Marco Pappalettera, Vittorio Carreri, Alessandro R Zanetti.   

Abstract

BACKGROUND: This study was designed to assess the risk of transmitting HCV and HIV by transfusion of antibody-screened blood and to estimate the additional reduction in risk that may be achieved through the implementation of direct viral detection assays in Italy. STUDY DESIGN AND METHODS: Clinical and laboratory data of 2,411,800 blood donations collected from repeat volunteer donors from 1996 through 2000 were analyzed. The risk of transmitting HCV or HIV from screened blood donated during the window period was estimated using a mathematical model.
RESULTS: The residual risk of donating antibody-negative infectious blood was estimated at 1 in 127,000 donations for HCV and 1 in 435,000 for HIV. The use of NAT should further reduce such risk by 83 percent for HCV and 50 percent for HIV.
CONCLUSION: The residual risk of HCV or HIV transmission through screened blood is currently very small in Italy. The implementation of direct viral detection assays can further improve the safety of blood supply.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12385408     DOI: 10.1046/j.1537-2995.2002.00173.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  7 in total

1.  Estimates of risk of window-period transmission of blood-borne viral diseases in Quebec.

Authors:  Marc Germain; Stéphanie Gélinas; Gilles Delage
Journal:  CMAJ       Date:  2004-03-30       Impact factor: 8.262

Review 2.  Safety of the blood supply in Latin America.

Authors:  Gabriel A Schmunis; Jose R Cruz
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection.

Authors:  Syria Laperche; Nadine Le Marrec; Annie Girault; Françoise Bouchardeau; Annabelle Servant-Delmas; Michèle Maniez-Montreuil; Pierre Gallian; Thierry Levayer; Pascal Morel; Nicole Simon
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  Incidence and Residual Risk of HIV, HBV and HCV Infections Among Blood Donors in Tehran.

Authors:  Hamid Reza Saber; Seyed Morteza Tabatabaee; Ali Abasian; Mostafa Jamali; Ebadollah SalekMoghadam; Bashir Hajibeigi; Seyed Moayed Alavian; Seyed Mohammad Mirrezaie
Journal:  Indian J Hematol Blood Transfus       Date:  2016-10-01       Impact factor: 0.900

5.  Multicenter evaluation of a semiautomated, standardized assay for detection of hepatitis B virus DNA in blood donations.

Authors:  Luisa Romanò; Claudio Velati; Lorella Baruffi; Laura Fomiatti; Giuseppe Colucci; Alessandro R Zanetti
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

6.  Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.

Authors:  Jo Anne Chiavetta; Michael Escobar; Alice Newman; Yaohua He; Pete Driezen; Shelley Deeks; Devon E Hone; Sheila F O'Brien; Graham Sher
Journal:  CMAJ       Date:  2003-10-14       Impact factor: 8.262

7.  An autoregressive integrated moving average model for short-term prediction of hepatitis C virus seropositivity among male volunteer blood donors in Karachi, Pakistan.

Authors:  Saeed Akhtar; Shafquat Rozi
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.